Treatment of Massive Pulmonary Embolism with TPA Infusion
Definition and Diagnosis of Massive PE
- Massive PE is defined as PE with shock and/or hypotension (systolic blood pressure <90 mmHg or a pressure drop of ≥40 mmHg for >15 minutes not caused by arrhythmia, hypovolaemia, or sepsis) 1, 3
- Diagnosis can be rapidly established with CTPA or echocardiography showing right ventricular dysfunction 2
- Evidence of acute cor pulmonale with high clinical suspicion can also establish diagnosis 1
TPA Administration Protocol for Massive PE
- The European Heart Journal recommends 100 mg rtPA infused over 2 hours as the standard regimen for massive PE 3, 4
- Alternative regimen: 0.6 mg/kg rtPA given as a bolus over 15 minutes (maximum 50 mg) 5
- For patients in cardiac arrest due to suspected massive PE, the Thorax journal recommends 50 mg alteplase bolus 2, 6
Considerations for Specific Regimens
- The 2-hour 100 mg rtPA infusion produces faster hemodynamic improvement compared to longer infusions 4, 7
- The 0.6 mg/kg rtPA bolus over 15 minutes may have a lower incidence of bleeding (11% vs 21-24% with 2-hour regimen) 1, 3
Timing and Initiation
- The European Heart Journal recommends initiating thrombolysis as soon as massive PE is diagnosed 1
- Greatest benefit is observed when treatment is initiated within 48 hours of symptom onset 7
- Angiographic confirmation is not required before initiating thrombolysis 1
Contraindications
- Most contraindications to thrombolytic therapy in massive PE are considered relative rather than absolute 1, 2
- In life-threatening massive PE, contraindications may be ignored if the benefit outweighs the risk 6
Post-Thrombolysis Management
- Heparin should be started after rtPA administration when the APTT is less than twice the upper limit of normal 5
- Recommended heparin dose: 1280 IU/hour as a continuous infusion 5
Monitoring and Expected Outcomes
- Monitor for clinical and echocardiographic improvement 4
- Expect improvement in pulmonary artery pressure (approximately 30% reduction) 4, 7
- Expect improvement in cardiac index (approximately 15% increase) 4, 7
Potential Complications
- Major bleeding occurs in approximately 11-24% of patients depending on the regimen 1, 3
- Allergic reactions may occur, particularly with streptokinase (not with rtPA) 5